EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Epigenetic Alterations in Colitis-Associated Colorectal Cancer

Nisha Ganesh, William M Grady, Andrew M Kaz iD

Epigenomes · 16.01.2026 · 10 (1) · 4

DOI: 10.3390/epigenomes10010004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Epigenomes, online erschienen am 16.01.2026. Verfasst von Nisha Ganesh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, School of Medicine, University of Washington, Seattle, WA 98105, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colitis-associated colorectal cancer (CAC) represents a distinct subtype of colorectal malignancy that arises in the setting of chronic inflammatory bowel disease (IBD). Unlike sporadic colorectal cancer, CAC develops through inflammation-driven molecular pathways, in which epigenetic alterations play a pivotal role in tumor initiation and progression. This review highlights the major epigenetic mechanisms implicated in CAC, including DNA methylation, histone modifications, and microRNA (miRNA) dysregulation. Aberrant DNA methylation patterns, such as promoter hypermethylation of tumor suppressor genes and global hypomethylation, contribute to genomic instability and altered gene expression. In parallel, inflammation-induced changes in histone configuration modulate chromatin accessibility and transcriptional activity of key oncogenic and tumor-suppressive pathways. Furthermore, deregulated miRNAs influence multiple aspects of CAC pathogenesis by targeting genes involved in inflammation and tumor progression. Understanding these epigenetic processes provides valuable insights into the development of colorectal malignancy and identifies potential biomarkers for early detection and intervention in colitis-associated colorectal cancer.

Schlagwörter

Stichwörter der Autor:innen

Crohn’s diseaseDNA methylationbiomarkerscolitis-associated colorectal cancerepigeneticshistone modificationsinflammatory bowel diseasemicro-RNAulcerative colitis

Autor:innen und Institutionen

  • Division of Gastroenterology, School of Medicine, University of Washington, Seattle, WA 98105, USA.
  • Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
  • Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
  • Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
  • GI Section, Hospital and Specialty Medicine, VA Puget Sound Healthcare System, Seattle, WA 98108, USA.

ORCID-Profile: Andrew M Kaz

Förderung

  • NCI NIH HHS
  • NCI

Zitieren

APA

Ganesh, N., Grady, W. M., & Kaz, A. M. (2026). Epigenetic Alterations in Colitis-Associated Colorectal Cancer. Epigenomes, 10(1), 4. https://doi.org/10.3390/epigenomes10010004

Vancouver

Ganesh N, Grady WM, Kaz AM. Epigenetic Alterations in Colitis-Associated Colorectal Cancer. Epigenomes. 2026;10(1):4. doi:10.3390/epigenomes10010004

BibTeX
@article{Ganesh2026,
  author = {Ganesh, Nisha and Grady, William M and Kaz, Andrew M},
  title = {Epigenetic Alterations in Colitis-Associated Colorectal Cancer},
  journal = {Epigenomes},
  year = {2026},
  volume = {10},
  number = {1},
  pages = {4},
  doi = {10.3390/epigenomes10010004}
}
Kostenlos starten →